Outcome of the second Medicines Utilisation Research in Africa Group meeting to promote sustainable and appropriate medicine use in Africa

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 17, Issue 2, 2017, Pages 149-152

  Massele, Amos ^a   Burger, Johanita ^b   Kalemeera, Francis ^c   Jande, Mary ^d   Didimalang, Thatayaone ^e   Kalungia, Aubrey Chichonyi ^f   Matshotyana, Kidwell ^g   Law, Michael ^h   Malone, Brighid ⁱ   Ogunleye, Olayinka ^j   Oluka, Margaret ^k   Paramadhas, Bene D ^l   Rwegerera, Godfrey ^a   Zinyowera, Sekesai ^m   Godman, Brian ^n,o  

^a UNIVERSITY OF BOTSWANA   (Botswana)

^b NORTH WEST UNIVERSITY   (South Africa)

^c UNIVERSITY OF NAMIBIA   (Namibia)

^d CATHOLIC UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^e Gaborone Private Hospital   (Botswana)

^f UNIVERSITY OF ZAMBIA   (Zambia)

^g Pharmaceuticals and Health Technology Group   (Swaziland)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ Bokamoso Private Hospital   (Botswana)

^j LAGOS STATE UNIVERSITY TEACHING HOSPITAL   (Nigeria)

^k UNIVERSITY OF NAIROBI   (Kenya)

^l Nyangabgwe Hospital   (Botswana)

^m MINISTRY OF HEALTH AND CHILD CARE   (Zimbabwe)

ⁿ KAROLINSKA INSTITUTE   (Sweden)

^o UNIVERSITY OF STRATHCLYDE   (United Kingdom)

more..

Author keywords

Adherence; Africa; antibiotics; ARVs; drug utilization; rational use of medicines

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIRETROVIRUS AGENT; AZITHROMYCIN; COTRIMOXAZOLE; TENOFOVIR DISOPROXIL; ANTIINFECTIVE AGENT;

AFRICA; CONFERENCE PAPER; DRUG FORMULARY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; INTERNATIONAL COOPERATION; KIDNEY FUNCTION; LONG TERM CARE; MEDICAL RESEARCH; MEDICATION COMPLIANCE; NAMIBIA; PHARMACY; POLICY; PREVALENCE; PUBLICATION; PURCHASING; HUMAN; ORGANIZATION AND MANAGEMENT; RESEARCH;

AFRICA; ANTI-INFECTIVE AGENTS; ANTI-RETROVIRAL AGENTS; DRUG UTILIZATION; HUMANS; RESEARCH;

EID: 84995700062     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1080/14737167.2017.1256775     Document Type: Conference Paper

References (16)

1. Massele A, Godman B, Adorka M, et al. Initiative to progress research on medicine utilization in Africa:formation of the Medicines Utilization Research in Africa group. Expert Rev Pharmacoecon Outcomes Res. 2015;15(4):607–610.
2. Gustafsson LL, Wettermark B, Godman B, et al. The ‘wise list’–a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm. Basic Clin Pharmacol Toxicol. 2011;108(4):224–233.•• Shows how high adherence can be achieved to a limited number of medicines even in a high income country.
3. Bjorkhem-Bergman L, Andersen-Karlsson E, Laing R, et al. Interface management of pharmacotherapy. Joint Hospital Primary Care Drug Recommendations Eur J Clin Pharmacol. 2013;69(Suppl 1):73–78.•• Illustrates ways to improve appropriate prescribing across sectors.
4. Ministry of Health and WHO. Standard treatment guidelines and essential medicines list of common medical conditions in the Kingdom of Swaziland. Available from: http://apps.who.int/medicinedocs/documents/s22119en/s22119en.pdf
5. Fadare JO, Adeoti AO, Desalu OO, et al. The prescribing of generic medicines in Nigeria:knowledge, perceptions and attitudes of physicians. Expert Rev Pharmacoecon Outcomes Res. 2016;16(5):639–650.
6. Akunne OO, Godman B, Adedapo AD, et al. Statin prescribing among hypertensive patients in southwest Nigeria:findings and implications for the future. J Comp Eff Res. 2016;5(3):281–288.
7. Mukonzo JK, Owen JS, Ogwal-Okeng J, et al. Pharmacogenetic-based efavirenz dose modification:suggestions for an African population and the different CYP2B6 genotypes. PLoS One. 2014;9(1):e86919.• Discusses the importance of pharmacogenomics for dosing efavirenz.
8. Gaida R, Truter I, Grobler C, et al. A review of trials investigating efavirenz-induced neuropsychiatric side effects and the implications. Expert Rev Anti Infect Ther. 2016;14(4):377–388.• Good meta analysis on the side-effects of efavirenz.
9. Moon JC, Godman B, Petzold M, et al. Different initiatives across Europe to enhance losartan utilization post generics:impact and implications. Front Pharmacol. 2014;5:219.
10. Godman B, Shrank W, Andersen M, et al. Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization:changes seen and global implications. Expert Rev Pharmacoecon Outcomes Res. 2010;10(6):707–722.
11. Massele A, Tiroyakgosi C, Matome M, et al. Research activities to improve the utilization of antibiotics in Africa. Expert Rev Pharmacoecon Outcomes Res. 2016;1–4.
12. Jande M, Kongola G, Mwangi JW., Drug prescribing pattern in two hospitals in Mwanza, Northwest Tanzania. East Cent Afr J Pharm Sci. 2012;15:63–68.
13. Kalungia AC, Burger J, Godman B, et al. Non-prescription sale and dispensing of antibiotics in community pharmacies in Zambia. Expert Rev Anti Infect Ther. 2016;14(12):1215–1223.•• Emphasizing the high rates of self-purchasing of antibiotics in Zambia despite current legislation.
14. Kalemeera F, Mbango C, Mubita M, et al. Effect of changing from first- to second-line antiretroviral therapy on renal function:a retrospective study based on data from a single health facility in Namibia. Expert Rev Anti Infect Ther. 2016;14(8):777–783.• Discusses the impact of changing ARVs on renal function in routine clinical care.
15. Membership forms MURIA. Available from: http://muria.nmmu.ac.za/Membership
16. Medicines Utilisation Research in Africa–Second MURIA Training Workshop and Symposium. Available from:http://muria.nmmu.ac.za/2nd-MURIA-Training-Workshop-and-Symposium,-25-27-J